Vivek Ghosh, Clinical Oncologist at Birat Cancer Institute, Nepal, Member of Two Worlds Cancer Collaboration, shared a post on LinkedIn:
“FASTRACK study showing excellent long-term outcomes with kidney cancer SBRT.
The study demonstrated 98% tumor control at 5 years with only 1-3 treatment sessions and low serious side effects.”
Other articles featuring Vivek Ghosh on OncoDaily.